Pharmaceutical Drug Delivery Market by Route (Oral (Tablet), Pulmonary (Nebulizer), Injectable, Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal), Application (Cancer, Diabetes), Patient Care Setting (Hospital)- COVID-19 Impact - Forecast to 2025

医薬品用ドラッグデリバリーの世界市場予測:ルート別(経口(錠剤)、肺(ネブライザー)、注入別、接眼レンズ別(液体)、局所別(固体)、埋め込み式別(アクティブ)、用途別(癌、糖尿病)、患者ケア環境別(病院)、新型コロナウイルス感染症の影響

◆タイトル:Pharmaceutical Drug Delivery Market by Route (Oral (Tablet), Pulmonary (Nebulizer), Injectable, Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal), Application (Cancer, Diabetes), Patient Care Setting (Hospital)- COVID-19 Impact - Forecast to 2025
◆商品コード:MD 3871
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年7月31日
◆ページ数:439
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥698,250見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥855,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は医薬品用ドラッグデリバリーの世界市場が2020年1兆4,305億ドルから2025年2兆153億ドルまで、年平均7.1%成長すると予想しています。本調査レポートでは、医薬品用ドラッグデリバリーの世界市場について、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、管理ルート別(経口ドラッグデリバリー、注射可能型ドラッグデリバリー、局所ドラッグデリバリー、経眼ドラッグデリバリー、経肺ドラッグデリバリー)分析、使用施設別(病院、外来手術センター/クリニック、在宅医療セッティング、診断センター、その他)分析、用途別(感染症、癌、心血管疾患、糖尿病、呼吸器疾患)分析、地域別分析、競争状況、企業情報などを総合的、多面的に調査・分析しました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・医薬品用ドラッグデリバリーの世界市場規模:管理ルート別(経口ドラッグデリバリー、注射可能型ドラッグデリバリー、局所ドラッグデリバリー、経眼ドラッグデリバリー、経肺ドラッグデリバリー)
・医薬品用ドラッグデリバリーの世界市場規模:使用施設別(病院、外来手術センター/クリニック、在宅医療セッティング、診断センター、その他)
・医薬品用ドラッグデリバリーの世界市場規模:用途別(感染症、癌、心血管疾患、糖尿病、呼吸器疾患)
・医薬品用ドラッグデリバリーの世界市場規模:地域別
・競争状況
・企業情報

“Rising prevalence for chronic diseases and growth in the biologics market are expected to drive the overall growth of the pharmaceutical drug delivery market.”
The global pharmaceutical drug delivery market is projected to reach USD 2,015.3 billion by 2025 from USD 1,430.5 billion in 2020, at a CAGR of 7.1% during the forecast period 2020-2025. Growth in this market is mainly driven by the rising prevalence of chronic diseases, growth in the biologics market, and technological advancements and new product launches. On the other hand, the risk of needlestick injuries and the increasing pricing pressure are expected to challenge market growth in the coming years.

“The home care settings segment is expected to grow at the highest CAGR during the forecast period.”
Based on facility of use, the pharmaceutical drug delivery market is segmented hospitals, ambulatory surgical centers (ASCs)/clinics, diagnostic centers, home care settings, and other facilities of use. The home care settings segment is expected to grow at a higher CAGR during the forecast period. This can majorly be attributed to increasing use of various drug delivery devices such as injectables, nebulizers, and inhalers in home care settings.

“The conventional injection devices segment accounted for the largest share of the injectable drug delivery market in 2019.”
Based on type, the injectable drug delivery technology is segmented into conventional injection devices, self-injection devices, and other devices. In 2019, conventional injection devices accounted for the largest share of the injectable drug delivery technology market. The large share of this segment can primarily be attributed to factors such as the low cost of devices and manufacturing, large molecular size of biologics administered through injectables, and the widespread popularity of conventional devices.

“North America to dominate the market during the forecast period.”
In 2019, North America accounted for the largest share of the pharmaceutical drug delivery market. The large share of the North American market is due to factors such as the rising prevalence of chronic diseases such as cancer, respiratory allergies, and diabetes; growth in biologics in the pharmaceuticals market; and the presence of a large number of prominent players in this region.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 (55%), Tier 2 (25%), and Tier 3 (20%)
• By Designation: C-level (43%), D-level (32%), and Others (25%)
• By Region: North America (38%), Europe (23%), Asia (29%), and RoW (10%)

List of Companies Profiled in the Report:
• Johnson & Johnson, Inc. (US)
• F. Hoffman-La Roche (Switzerland)
• Merck & Co., Inc. (US)
• Bayer AG (Germany)
• Pfizer, Inc. (US)
• Novartis AG (Switzerland)
• 3M Company (US)
• Becton, Dickinson and Company (US)
• GlaxoSmithKline plc, (UK)
• Sanofi (France)
• Antares Pharma, Inc. (US)
• AbbVie (US)
• Amgen (US)
• Boehringer Ingelheim (Germany)
• AstraZeneca (UK)
• Eli Lilly and Company (US)
• Gilead Sciences, Inc. (US)
• Teva Pharmaceuticals (Israel)
• Bristol-Myers Squibb (US)
• Genmab A/S (Denmark)

Research Coverage:
This report provides a detailed picture of the global pharmaceutical drug delivery market. It aims at estimating the size and future growth potential of the market across different segments, such as route of administration, application, facility of use, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Reasons to Buy the Report:
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:
 Market Penetration: Comprehensive information on the product portfolios of the top players in the pharmaceutical drug delivery market. The report analyzes this market by type, application, route of administration, end user, and region
 Market Development: Comprehensive information on the lucrative emerging markets, by application, end user, and region
 Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the pharmaceutical drug delivery market
 Competitive Assessment: In-depth assessment of growth strategies, product offerings, and capabilities of the leading players in the pharmaceutical drug delivery market

【レポートの目次】



★調査レポート[医薬品用ドラッグデリバリーの世界市場予測:ルート別(経口(錠剤)、肺(ネブライザー)、注入別、接眼レンズ別(液体)、局所別(固体)、埋め込み式別(アクティブ)、用途別(癌、糖尿病)、患者ケア環境別(病院)、新型コロナウイルス感染症の影響] ( Pharmaceutical Drug Delivery Market by Route (Oral (Tablet), Pulmonary (Nebulizer), Injectable, Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal), Application (Cancer, Diabetes), Patient Care Setting (Hospital)- COVID-19 Impact - Forecast to 2025 / MD 3871) 販売に関する免責事項
[医薬品用ドラッグデリバリーの世界市場予測:ルート別(経口(錠剤)、肺(ネブライザー)、注入別、接眼レンズ別(液体)、局所別(固体)、埋め込み式別(アクティブ)、用途別(癌、糖尿病)、患者ケア環境別(病院)、新型コロナウイルス感染症の影響] ( Pharmaceutical Drug Delivery Market by Route (Oral (Tablet), Pulmonary (Nebulizer), Injectable, Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal), Application (Cancer, Diabetes), Patient Care Setting (Hospital)- COVID-19 Impact - Forecast to 2025 / MD 3871) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆